Safety of COVID-19 vaccine in patients with myasthenia gravis: a self-controlled case series study
BackgroundThe safety of COVID-19 vaccines has been clarified in clinical trials; however, some immunocompromised patients, such as myasthenia gravis (MG) patients, are still hesitant to receive vaccines. Whether COVID-19 vaccination increases the risk of disease worsening in these patients remains u...
Main Authors: | Zhe Ruan, Xiao Huan, Yue Su, Yong-Lan Tang, Dong-Dong Meng, Da-Lin Ren, Chun-Hong Li, Si-Jia Hao, Chong-Bo Zhao, Su-Shan Luo, Zhu-Yi Li, Ting Chang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-05-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1141983/full |
Similar Items
-
COVID-19 Vaccination in Patients with Myasthenia Gravis: A Single-Center Case Series
by: Zhe Ruan, et al.
Published: (2021-09-01) -
Safety of inactivated SARS-CoV-2 vaccines in myasthenia gravis: A survey-based study
by: Hong-Yan Li, et al.
Published: (2022-08-01) -
IMMUNOPATHOGENESIS OF MYASTHENIA GRAVIS (REVIEW)
by: E. D. Gasymly
Published: (2018-06-01) -
Myasthenia Gravis Exacerbation Following COVID-19 Vaccine: A Case Report
by: Thoybah Yousif Ibrahim Gabralla, et al.
Published: (2023-03-01) -
The safety of COVID-19 vaccines in patients with myasthenia gravis: A scoping review
by: Siyang Peng, et al.
Published: (2022-12-01)